Specify a stock or a cryptocurrency in the search bar to get a summary
Sequent Scientific Limited
SEQUENTSequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments. Address: Dosti Pinnacle, Mumbai, India, 400604
Analytics
WallStreet Target Price
11 271.84 INRP/E ratio
1014.8572Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SEQUENT
Dividend Analytics SEQUENT
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
12 %Dividend History SEQUENT
Stock Valuation SEQUENT
Financials SEQUENT
Results | 2019 | Dynamics |